The hereditary cancer screening panel is a comprehensive panel that analyzes 275 genes associated with various cancers. Specific genes and mutations are targeted using next-generation sequencing technology; even low-frequency variants can be detected.
By providing a broad analysis of the cancer genome, it increases the likelihood of detecting clinically significant alterations and expands treatment options.
Who Should Be Tested?
- Individuals with a personal history of early-onset cancer or multiple primary cancers
- Individuals with a family history of cancer across multiple generations
- Cases where a single targeted panel is not sufficient
Panel Scope
The panel covers a total of 275 genes associated with various cancers, including breast, ovarian, uterine, prostate, gastric and colorectal cancers.